Viewing Study NCT04479267


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-01-05 @ 12:46 PM
Study NCT ID: NCT04479267
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-29
First Post: 2020-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-Cell Lymphoma View
None High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements View
None High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6 Rearrangements View
None Double Expressor Lymphoma View
None High-grade B-cell Lymphoma View
Keywords: